• Taking Global Action Toward Improved Care, Quality of Life, and Empowerment for Older People with HIV - A Webinar
   
  
• Glasgow: The Glasgow Manifesto International Coalition of Older People with HIV (iCOPe HIV) - (10/26/22)
   
  
• Lenacapavir in first-line therapy - (01/27/23)
   
  
• Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled, phase 2 trial - (01/27/23)
   
  
• NYS Aging HIV RFP May 2022 - People Aging with HIV (PAWH) - (01/24/23)
   
  
• Exercise Reduced Heart Attacks & All-Cause Mortality - (01/24/23)
   
  
• HTPN 078: an enhanced case management study to achieve viral suppression among viremic HIV-positive men who have sex with men in the United States; can we reach ETE & 90/90/90 ? - (01/23/23)
   
  
• kidney disease increases 4-fold in NYC Clinic from <50 to > 75 from 7% to 31%; high Rates Mental & physical of Comorbidities at large NYC HIV clinic - (01/23/23)
   
  
More HIV Articles...
 

• HEPATITIS D INFECTION: who should be screened AASLD 2018 HBV Guidelines
   
  
• Low Performance of Hepatitis Delta Virus Testing Among 2 National Cohorts of Chronic Hepatitis B Patients in the United States - (01/24/23)
   
  
• Hepatitis D (Delta) Course Review: Conference Reports: USA/Global Prevalence, Mortality-HCC Impact, PWIDs, Treatment, Screening, Patient Support - (01/13/23)
   
  
More Hep D Articles...
 


---


 
Aging & Perinatally HIV Infected
 

• The Impact of HIV- and ART-Induced Mitochondrial Dysfunction in Cellular Senescence and Aging - (01/25/23)
   
  
• Atazanavir Induced Senesence in Mice But Not Darunavir - (01/25/23)
   
  
• Increased incidence of glaucoma medication usage in middle-aged Australian males taking antiretroviral medication - a population-based study - (01/25/23)
   
  
• Empagliflozin and Assessment of Lower-Limb Amputations in the EMPA-REG OUTCOME Trial - (01/25/23)
   
  
• Diabetic Kidney Disease, HIV, Women - (01/24/23)
   
  
• Effects of SGLT2 inhibitors on fractures and bone mineral density in type 2 diabetes: An updated metaanalysis - (01/24/23)
   
  
Aging & Perinatally HIV Articles...
 
More Aging & HIV Articles...
 


---


 
Mpox
 

• MPXV Transmission at a Tattoo Parlor - (01/06/23)
   
  
• Characteristics and clinical manifestations of monkeypox among people with and without HIV in the United States: A retrospective cohort - (12/08/22)
   
  
More Monkeypox Articles...
 

• Modelling the potential effectiveness of hepatitis C screening and treatment strategies during pregnancy in Egypt and Ukraine - (01/18/23)
   
  
• New Street Drugs Xylazine + Fentanyl Replacing "street heroin" - Widespread Distribution of Xylazine Detected Throughout the United States in Healthcare Patient Samples - (01/10/23)
   
  
• Increasing presence of xylazine in heroin and/or fentanyl deaths, Philadelphia, Pennsylvania, 2010-2019 - Fentanyl & xylazine have replaced heroin in "street heroin" - (01/10/23)
   
  
• "Travesty" of US Not Dealing with HCV - (01/07/23)
   
  
• IDUs - HCV DAA High Adherence 90% & SVR Among IDUs at Buffalo Clinic - (01/22/22)
   
  
• Postpartum Follow-up Care for Pregnant Persons With Opioid Use Disorder and Hepatitis C Virus Infection - (01/22/22)
   
  
• Reverse inflammaging: Long-term effects of HCV cure on biological age - (12/22/22)
   
  
• Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus Treatment - (12/21/22)
   
  
• Low Treatment & SVR Rates on MOUD - Medications for opioid use disorder (MOUD; eg, buprenorphine, methadone, and extended-release naltrexone), 10.6% SVR - (12/21/22)
   
  
More Hep C Articles...
 

• New Approaches to Chronic Hepatitis B - (01/06/23)
   
  
• HBV Panel: New Screening/Treatment Recommendations - It Is Time for a Simplified Approach to Hepatitis B Elimination, Editorial too. - (01/06/23)
   
  
• AASLD: Low level of hepatitis B viremia increases the risk of hepatocellular carcinoma in patients with untreated compensated cirrhosis - (11/28/22)
   
  
• AASLD: Profile of HBV DNA integration in the natural history of chronic hepatitis B - (11/28/22)
   
  
• AASLD: Comparable outcomes between immune-tolerant and active phases in non-cirrhotic chronic hepatitis B: a meta-analysis - (11/28/22)
   
  
More Hep B Articles...
 


---


 
Fatty Liver, NAFLD, NASH
 

• OCA Obeticholic Acid Update at NASH-TAG Jan 5 2023 - (01/16/23)
   
  
• Intercept Announces Efficacy and Safety Data from Phase 3 REGENERATE Study in Liver Fibrosis due to NASH to be Presented at NASH-TAG Conference 2023 - press release    - (01/16/23)
   
  
• Intercept Resubmits New Drug Application to U.S. FDA for Obeticholic Acid in Patients with Liver Fibrosis due to NASH - press release    - (01/16/23)
   
  
• New NASH Resmetirom Phase 3 Data at NASH-TAG Conference Jan 5    - (01/16/23)
   
  
More Fatty Liver Articles...
 

List not necessarily listed here in order of date being held.